ScholarIQanswers from OpenAlex

Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group

PaperCitations, authors & open-access status

Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group have?

ScholarIQcitation count

Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group has 49 citations in the OpenAlex counts ScholarIQ stores.

When was Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group published?

ScholarIQyear

Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group has 2023 year in the ScholarIQ index.

What is the open-access status of Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group?

ScholarIQoa status

Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group has gold oa status in the ScholarIQ index.

What is the DOI of Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group?

ScholarIQdoi

The DOI for Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group is on the source record.

What is the PMID of Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group?

ScholarIQpmid

The PMID for Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group is on the source record.

What is the OpenAlex record for Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group?

ScholarIQopenalex

The OpenAlex for Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial